Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Tetratherix Limited ( (AU:TTX) ) just unveiled an announcement.
Tetratherix Limited’s 2025 Annual General Meeting highlighted a successful year marked by the company’s ASX listing and progress in its commercialization strategies. The company is on track with its goals, supported by the IGP Grant, and remains committed to long-term shareholder value through the Tetramatrix Platform, balancing commercial opportunities with governance standards.
The most recent analyst rating on (AU:TTX) stock is a Buy with a A$5.76 price target. To see the full list of analyst forecasts on Tetratherix Limited stock, see the AU:TTX Stock Forecast page.
More about Tetratherix Limited
Tetratherix Limited operates in the biotechnology industry, focusing on the development and commercialization of the Tetramatrix Platform, which aims to improve patient outcomes through innovative technology.
Average Trading Volume: 12,857
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$106.2M
See more insights into TTX stock on TipRanks’ Stock Analysis page.